EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

New Thieno[3,2-d]pyrimidin-4(3H)-one Schiff Bases as Selective Antileishmanial Agents

Neriman Mor iD, Barış Yıldız iD, Baycan Mor iD, Feyzi Sinan Tokalı iD

Life · 10.06.2026 · 16 (6) · 979

DOI: 10.3390/life16060979 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life, online erschienen am 10.06.2026. Verfasst von Neriman Mor und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Parasitology, Faculty of Medicine, Kafkas University, 36100 Kars, Türkiye. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kafkas University, Kafkas University Scientific Research Projects Coordination Unit.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present study aimed to design, synthesize, and evaluate a new series of thieno[3,2-d]pyrimidin-4(3H)-one-based Schiff bases as potential antileishmanial agents against Leishmania major (L. major). A series of twenty thieno[3,2-d]pyrimidine Schiff base derivatives were synthesized and characterized using FTIR, NMR, and HRMS techniques. Their antipromastigote activities were evaluated in vitro against L. major, while cytotoxic effects were assessed on HUVECs to determine selectivity indices. The most active compound was further investigated using molecular docking against several L. major proteins. Among the tested compounds, compound 12, bearing a 2-hydroxy-5-bromophenyl moiety, exhibited the most potent activity against L. major promastigotes with an IC50 value of 13.7 µM, along with a favorable selectivity index (SI = 17.5), outperforming the reference drug miltefosine (IC50 = 31 µM and SI = 0.2). Docking studies demonstrated that compound 12 showed the strongest binding affinity toward phosphodiesterase B1, supported by a docking score of −9.042 kcal/mol and an MM-GBSA value of −67.21 kcal/mol. This study highlights thieno[3,2-d]pyrimidin-4(3H)-one as a promising scaffold in the context of in vitro antileishmanial screening and suggests the role of ortho-phenolic substitution in enhancing activity and selectivity. Compound 12 emerges as a promising lead, warranting further optimization and biological evaluation in future studies.

Schlagwörter

Stichwörter der Autor:innen

L. majorSchiff basesantileishmanialeishmaniasisthieno[3,2-d]pyrimidin-4(3H)-one

Autor:innen und Institutionen

  • Department of Medical Parasitology, Faculty of Medicine, Kafkas University, 36100 Kars, Türkiye.
  • Life Sciences and Technologies Application and Research Center, Kafkas University, 36000 Kars, Türkiye.
  • Department of Molecular Biology and Genetics, Faculty of Sciences and Letters, Kafkas University, 36100 Kars, Türkiye.
  • Department of Material and Material Processing Technologies, Kars Vocational School, Kafkas University, 36100 Kars, Türkiye.

ORCID-Profile: Neriman Mor, Barış Yıldız, Baycan Mor, Feyzi Sinan Tokalı

Förderung

  • Kafkas University
  • Kafkas University Scientific Research Projects Coordination Unit

Zitieren

APA

Mor, N., Yıldız, B., Mor, B., & Tokalı, F. S. (2026). New Thieno[3,2-d]pyrimidin-4(3H)-one Schiff Bases as Selective Antileishmanial Agents. Life, 16(6), 979. https://doi.org/10.3390/life16060979

Vancouver

Mor N, Yıldız B, Mor B, Tokalı FS. New Thieno[3,2-d]pyrimidin-4(3H)-one Schiff Bases as Selective Antileishmanial Agents. Life. 2026;16(6):979. doi:10.3390/life16060979

BibTeX
@article{Mor2026,
  author = {Mor, Neriman and Yıldız, Barış and Mor, Baycan and Tokalı, Feyzi Sinan},
  title = {New Thieno[3,2-d]pyrimidin-4(3H)-one Schiff Bases as Selective Antileishmanial Agents},
  journal = {Life},
  year = {2026},
  volume = {16},
  number = {6},
  pages = {979},
  doi = {10.3390/life16060979}
}
Kostenlos starten →